Trinity Biotech logo
TRIBTrinity Biotech
Trade TRIB now
Trinity Biotech primary media

About Trinity Biotech

Trinity Biotech (NASDAQ:TRIB) specializes in the development, manufacture, and marketing of clinical diagnostic products for the healthcare industry. Its offerings cater to the segments of infectious disease, clinical laboratory, and point-of-care. Trinity Biotech is traded on the NASDAQ under the symbol TRIB. The company aims to innovate and expand its diagnostics portfolio, focusing on enhancing healthcare outcomes by providing rapid, reliable testing solutions. With operations and strategic partnerships worldwide, Trinity's projects include advancing diagnostic technologies, improving existing product lines, and achieving operational excellence to meet the evolving needs of the global healthcare market.

What is TRIB known for?

Snapshot

Public US
Ownership
1992
Year founded
380
Employees
Bray, Ireland
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Ireland

Produtos e/ou serviços de Trinity Biotech

  • HIV rapid test kits for accurate, on-site diagnosis of HIV-1 and HIV-2 infections.
  • Clinical chemistry reagents used for routine biochemical analysis to assess various bodily functions.
  • Autoimmune diagnostics including assays and instruments for detecting autoimmune diseases.
  • Diabetes monitoring tests designed to measure glycated hemoglobin levels, aiding in diabetes management.
  • Point-of-care tests for infectious diseases, enabling quick diagnosis of conditions like syphilis and malaria.
  • Haemostasis products to aid in assessing blood clotting disorders and managing anticoagulant therapy.

equipe executiva do Trinity Biotech

  • Mr. John GillardPresident, CEO, Company Secretary & Director
  • Mr. Ronan O'Caoimh A.C.A.Founder, Director & Executive Advisor
  • Dr. James Walsh Ph.D.Executive Director of Business Development & Executive Director
  • Ms. Jacqueline O'NeillDirector of Operations
  • Dr. Gary Keating Ph.D.Chief Technology Officer
  • Ms. Eibhlin KellyChief Information Officer
  • Mr. Colm MolloyGroup Director of Human Resources & Culture

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.